Please login to the form below

SMC

This page shows the latest SMC news and features for those working in and with pharma, biotech and healthcare.

The treatment is also under review by the Scottish Medicines Consortium (SMC) in Scotland and a decision expected later this year.

AbbVie’s Rinvoq accepted by SMC for atopic dermatitis

AbbVie has announced that the Scottish Medicines Consortium (SMC) has accepted Rinvoq (upadacitinib) as a treatment of atopic dermatitis (eczema) for people who are 12 years or older. ... The SMC has now approved Rinvoq for the treatment of psoriatic
Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis

It was then made available to patients in Scotland in November 2020, following acceptance from the Scottish Medicines Consortium (SMC).
Seagen’s Tukysa granted NICE recommendation for breast cancer patients

NICE’s decision follows the Scottish Medicines Consortium (SMC) acceptance of tucatinib combination treatment, for use in NHS Scotland on 17 January.
SMC approves Biogen’s Vumerity for patients with multiple sclerosis

Biogen’s Vumerity (diroximel fumarate) has been approved by the Scottish Medicines Consortium (SMC) as an oral treatment for adults with relapsing-remitting multiple sclerosis (RRMS). ... With this latest decision from the SMC, Biogen is able to
SMC approves Parkinson’s disease treatment Ongentys

Bial has announced that its treatment Ongentys (opicapone) has been accepted for use within NHS Scotland after a review published by the Scottish Medicines Consortium (SMC). ... The SMC’s decision indicates that the treatment may be administered to

More from news
Approximately 16 fully matching, plus 82 partially matching documents found.

NICE – but not enough

Olumiant launched in 2017 and received positive recommendations from NICE and SMC in the middle of Q3 that same year.
The Orkambi row explained

December 2018: Scottish Government agrees a deal with Vertex pending submission of Orkambi and Symkevi to Scottish Medicines Consortium (SMC), with interim access possible through the PACS Tier 2 system.
The Orkambi blame game

Leiden also claimed the breakthrough in Scotland came when NICE’s equivalent, the SMC, agreed to ‘flex’ its methodology – something which he and other industry leaders said is vital if NICE
Patient involvement in health technology assessment

We have developed a Public Involvement Network (PIN) that formalises relationships with each submitting patient group through a registration process to become an SMC Patient Group Partner. ... SMC as a respected partner in developing and shaping all
The reality of real-world evidence

Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

YorkTown

decision makers associated with pharmaceutical and medical device/diagnostics market access and HEOR; Developing and writing single technology appraisals (STA) (pharmaceutical and medical device) for regulatory institutions (NICE, EMA, SMC and
The Holistic Approach to Market Access

and to provide local prescribing audit data for inclusion into NICE and SMC technical appraisals the gaining of which is a key element in gaining regional prescribing uptake.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Country Manager, Healthcare Communications Agency, Germany: Highly competitive salary

Add my company

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...

The communication challenge of helping he next generation to be healthier: As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?: We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
How the Royal Society’s EiR programme can help to drive UK innovation: ...

Email:
Password: